Investigate interactive roles of environmental, behavioral and genetic factors on racial disparities in breast cancer outcomes
Investigate interactive roles of environmental, behavioral and genetic factors on racial disparities in breast cancer outcomes
批准号:
10655049
负责人:
Yaguang Xi
金额:
$11.03万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
AddressAdministrative SupplementAfrican AmericanAgeAll of Us Research ProgramBehaviorBehavioralBehavioral GeneticsBiological MarkersBiomedical ResearchBody mass indexBreast Cancer PatientCaregiversCharacteristicsCommunitiesComplexComputer softwareConsensusDataData SetDatabasesDeath RateElectronic Health RecordEnvironmentEnvironmental Risk FactorEthnic OriginEtiologyGene ExpressionGeneticGenetic DatabasesGenetic Predisposition to DiseaseHealthHealth Disparities ResearchHealthcareHispanic PopulationsIncidenceIndividualInternetInterventionKnowledgeLinkMalignant NeoplasmsMeasurementMeasuresMediationMethodologyMethodsModelingOutcomeParticipantPatientsPhysical activityPlayPollutionProviderPublic HealthQuality of lifeRaceRecurrenceReduce health disparitiesRegistriesReportingResearchResearch PersonnelRisk FactorsRoleSmoking BehaviorStatistical MethodsSurveysTestingThe Cancer Genome AtlasUnited StatesVital StatusWomananalytical toolapplication programming interfacebreast cancer progressioncancer health disparitydata registrydemographicsdesigndisparity reductionepidemiology studyfollow-upgenetic informationhealth datahealth disparityhealth related quality of lifeimprovedmalignant breast neoplasmneoplasm registrynovelpersonalized medicineprecision medicineracial and ethnic disparitiesracial disparityrisk variantsocial determinantstreatment risktreatment strategytriple-negative invasive breast carcinomatumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Health disparities exist widely in the breast cancer outcomes (incidence, survival, and quality-of-life). When
compared with white women, African American women have higher recurrence and death rates from breast
cancer although they have a lower incidence rate. It is well established that both community and individual level
risk factors play important roles in breast cancer outcomes. In our previous studies, we have developed a
mediation analysis method to identify new biomarkers that contribute to health disparities in triple-negative breast
cancer (TNBC). We also developed a new multilevel mediation analysis method that allows for longitudinal
assessments of both residential environments and individual risk factors to be jointly utilized in determining the
mechanistic link between race and health outcomes. By including measures of individual and environmental
factors, our methods are capable of explaining existing disparities in health outcomes.In this project, we aim to
utilize the comprehensive database collected by the All of Us project to investigate the observed racial disparities
in breast cancer outcomes. Using the novel multilevel mediation analysis method, we will identify modifiable
factors that can explain the racial disparities observed in breast cancer outcomes. The risk factors to be
considered include measures at both the environmental (e.g. pollution measurements) and individual levels (e.g.,
smoking behavior and gene expressions). The information will help caregivers design precision medicine and
policymakers evaluate interventions that aim at improving treatment and reducing health disparities. We have
implemented our method as an R package (mlma) to provide the research community with open access to
software for performing multilevel mediation analysis. We plan to further develop an API for an interactive web
implementation of the software so that all researchers can use the method without the programming requirement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10889411
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2023
-
负责人:Yaguang Xi
-
依托单位:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
-
批准号:10889412
-
项目类别:
-
资助金额:$56.3万
-
财政年份:2023
-
负责人:Yaguang Xi
-
依托单位:
Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences
-
批准号:10594746
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2023
-
负责人:Yaguang Xi
-
依托单位:
MiR-17 mediates sulindac anti-metastatic activity in human colorectal cancer
-
批准号:10258119
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Yaguang Xi
-
依托单位:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
-
批准号:10538823
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2022
-
负责人:Yaguang Xi
-
依托单位:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10313128
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2021
-
负责人:Yaguang Xi
-
依托单位:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
-
批准号:10477444
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2021
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA and colorectal cancer chemoprevention
-
批准号:9325302
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2015
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA and colorectal cancer chemoprevention
-
批准号:9313603
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2015
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression
-
批准号:8707735
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2014
-
负责人:Yaguang Xi
-
依托单位:
MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression
-
批准号:8836988
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2014
-
负责人:Yaguang Xi
-
依托单位:
海外基金